Targeting angiogenesis for liver cancer: Past, present, and future

Liver cancer, mostly hepatocellular carcinoma (HCC), is the second leading cause of cancer mortality globally. Most patients were diagnosed at an advanced stage, and systemic therapy is the standard of care. All the approved systemic therapies for HCC are molecular targeted therapies with anti-angio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiao-Dong, Tang, Zhao-You, Sun, Hui-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452391/
https://www.ncbi.nlm.nih.gov/pubmed/32884987
http://dx.doi.org/10.1016/j.gendis.2020.03.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452391/
https://www.ncbi.nlm.nih.gov/pubmed/32884987
http://dx.doi.org/10.1016/j.gendis.2020.03.010

Ejemplares similares